Skip to main navigation
Skip to search
Skip to main content
The Aga Khan University Home
Search content at The Aga Khan University
Home
Profiles
Research units
Research output
Pharmacologic management of PCOS: Menstrual irregularities
Farheen Yousuf
,
Rehana Rehman
Department of Biological & Biomedical Sciences, Medical College, Pakistan
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
›
peer-review
1
Citation (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pharmacologic management of PCOS: Menstrual irregularities'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Oral Contraceptive Agent
100%
Menstrual Irregularity
100%
Polycystic Ovary Syndrome
100%
Progesterone
75%
Menstrual Cycle
50%
Anovulation
50%
Hyperandrogenism
50%
Lifestyle Modification
25%
Cell Proliferation
25%
Glycon
25%
Insulin Resistance
25%
Antiandrogen
25%
Menstruation Disorder
25%
Follitropin
25%
Cancer
25%
Endometrial Hyperplasia
25%
Insulin Sensitizing Agent
25%
Inositol
25%
Androgen
25%
Diethylstilbestrol
25%
Luteinizing Hormone
25%
Estradiol Valerate
25%
Drospirenone
25%
Cyproterone
25%
Side Effect
25%
Pharmacology, Toxicology and Pharmaceutical Science
Oral Contraceptive Agent
100%
Menstrual Irregularity
100%
Ovary Polycystic Disease
100%
Progesterone
75%
Hyperandrogenism
50%
Anovulation
50%
Estradiol Valerate
25%
Endometrium Hyperplasia
25%
Menstruation Disorder
25%
Follitropin
25%
Metformin
25%
Antiandrogen
25%
Inositol
25%
Insulin Sensitizing Agent
25%
Androgen
25%
Luteinizing Hormone
25%
Insulin Resistance
25%
Diethylstilbestrol
25%
Drospirenone
25%
Cyproterone
25%
Side Effect
25%
Agricultural and Biological Sciences
Combined Oral Contraceptive Pill
100%
Progesterone
75%
Menstrual Cycle
50%
Anovulation
50%
Hyperandrogenism
50%
Insulin Resistance
25%
Follicle-Stimulating Hormone
25%
Luteinizing Hormone
25%
Diethylstilbestrol
25%
Estradiol Valerate
25%
Cyproterone
25%
Cell Proliferation
25%
Inositol
25%
Androgen
25%
Drospirenone
25%
Veterinary Science and Veterinary Medicine
Hyperplasia
25%